Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizo-Affective Type of Psychosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03751488
What this trial is testing

Determine Pharmacokinetic Characteristics of LY03010 Versus INVEGA SUSTENNA® in Schizophrenia Patients

Who this might be right for
Schizo Affective DisorderSchizophreniaSchizoaffective Disorder
Luye Pharma Group Ltd. 48
Not applicableNot Yet RecruitingNCT06474325
What this trial is testing

Feasibility and Acceptability of Mobile Mental Health App for SZ and SZA

Who this might be right for
SchizophreniaSchizo Affective Disorder
University of Pittsburgh 44
Not applicableStudy completedNCT01321177
What this trial is testing

An Integrated Program for the Treatment of First Episode of Psychosis

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+2 more
Northwell Health 404
Post-approval studies (Phase 4)Study completedNCT00303602
What this trial is testing

Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder
Eli Lilly and Company 149
Large-scale testing (Phase 3)Study completedNCT00236457
What this trial is testing

A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaPsychotic Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 629
Large-scale testing (Phase 3)Study completedNCT00148083
What this trial is testing

Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
University of Illinois at Chicago 5
Testing effectiveness (Phase 2)Study completedNCT05643196
What this trial is testing

Focused Ultrasound Modulation of the Globus Pallidus Interna in Schizophrenia

Who this might be right for
SchizophreniaSchizophrenia Schizoaffective
NYU Langone Health 15
Large-scale testing (Phase 3)Study completedNCT01143090
What this trial is testing

Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Sumitomo Pharma America, Inc. 149
Not applicableStudy completedNCT03921450
What this trial is testing

Overcoming Psychomotor Slowing in Psychosis (OCoPS-P)

Who this might be right for
Schizophrenia and Related DisordersSchizophreniaSchizoaffective Disorder+1 more
University of Bern 103
Early research (Phase 1)Ended earlyNCT02149823
What this trial is testing

Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations

Who this might be right for
Borderline Personality DisorderBPDSchizotypal Personality Disorder+5 more
Maria de las Mercedes Perez Rodriguez 92
Large-scale testing (Phase 3)UnknownNCT01280305
What this trial is testing

Raloxifene in Treatment of Schizophrenia and Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Sheba Medical Center 200
Not applicableStudy completedNCT00749970
What this trial is testing

Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
AstraZeneca 100
Not applicableStudy completedNCT00237796
What this trial is testing

Functional Rehabilitation of Older Patients With Schizophrenia

Who this might be right for
Psychotic DisordersSchizoaffective DisorderSchizophrenia
US Department of Veterans Affairs 116
Not applicableStudy completedNCT00791440
What this trial is testing

Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
New York State Psychiatric Institute 34
Not applicableActive Not RecruitingNCT04033679
What this trial is testing

The Effects of Non-invasive Brain Stimulation on Treatment Adherence in Schizophrenia

Who this might be right for
Schizophrenia;Schizoaffective
Centre for Addiction and Mental Health 106
Not applicableLooking for participantsNCT06221852
What this trial is testing

Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder

Who this might be right for
Bipolar I DisorderPsychosisSchizoaffective Disorder
Mclean Hospital 50
Post-approval studies (Phase 4)Study completedNCT00190749
What this trial is testing

Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Eli Lilly and Company 130
Not applicableEnded earlyNCT03741751
What this trial is testing

Repetitive TMS & Cognitive Training in Adults With Schizophrenia

Who this might be right for
Schizophrenia Spectrum and Other Psychotic DisordersCognitive Impairment
Washington University School of Medicine 12
Post-approval studies (Phase 4)Study completedNCT00649064
What this trial is testing

The Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic Drugs

Who this might be right for
Schizoaffective DisorderSchizophrenia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 46
Large-scale testing (Phase 3)Study completedNCT00132314
What this trial is testing

Long-Acting Injectable Risperidone in the Treatment of Schizophrenia

Who this might be right for
Schizoaffective DisorderSchizophrenia
US Department of Veterans Affairs 382
Next Page